Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hand-Foot Syndrome × Pyridoxine × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Drug-Related Side Effects and Adverse Reactions 2 Breast Neoplasms 2 Ovarian Neoplasms 1 Hand-Foot Syndrome 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1

Interventions

tegafur-gimeracil-oteracil 1 mecobalamin 1 S 1 (combination) 1 Pyridoxine 1 Celecoxib 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00486213 2015-09-24

Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

National Cancer Centre, Singapore

Phase 3 Terminated

Hand-Foot Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡